FDA loses in court in campaign against Ivermectin COVID-19 treatment
Starting 2021, the FDA mounted a campaign against ivermectin – an inexpensive, Nobel Prize-winning medication that showed promising signs in the early treatment of COVID-19. While the death toll from this campaign is difficult to calculate, the impact was far-reaching. The campaign was used as fuel to terminate employment of doctors who understood the science […]